KRT19 and metabolic dysfunction-associated steatohepatitis: Samples from patients with NASH and PSC also demonstrated co‐localization of Fn14 (green) and CK19 (red), a biliary marker that highlights bile ducts and areas of ductular reactivity (Supplementary Figure S2).